Revision history of "Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers" (Q36252226)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 April 2022

26 March 2022

31 October 2021

18 April 2021

28 June 2020

2 January 2020

27 March 2019

3 January 2019

25 October 2017

  • curprev 06:2906:29, 25 October 2017 Emijrpbot talk contribs 20,158 bytes +4,693 Updated Item: BOT - Adding descriptions (57 languages): ast, bg, bn, ca, cs, da, de, el, eo, es, et, fa, fi, fr, gl, he, hu, hy, it, ja, ka, ko, lt, nan, nb, nl, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cy... undo (restore)

17 October 2017

13 August 2017